Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy - A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

被引:279
作者
Nathan, D. M. [1 ]
Buse, J. B.
Davidson, M. B.
Heine, R. J.
Holman, R. R.
Sherwin, R.
Zinman, B.
机构
[1] Massachusetts Gen Hosp, Ctr Diabet, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA
[4] Charles R Drew Univ Med & Sci, Clin Trial Unit, Los Angeles, CA 90059 USA
[5] Vrije Univ Amsterdam, Med Ctr, Ctr Diabet, Amsterdam, Netherlands
[6] Univ Oxford, Diabet Trials Unit, Oxford Ctr Diabet, Oxford OX1 2JD, England
[7] Yale Univ, Sch Med, Dept Internal Med & Endocrinol, New Haven, CT 06520 USA
[8] Univ Toronto, Mt Sinai Hosp, Dept Endocrinol, Toronto, ON M5G 1X5, Canada
[9] Univ Toronto, Mt Sinai Hosp, Dept Metab, Toronto, ON M5G 1X5, Canada
关键词
D O I
10.1007/s00125-006-0316-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This document was reviewed and approved by the Professional Practice Committee of the American Diabetes Association and by an ad hoc committee of the European Association for the Study of Diabetes ( U. Smith, Gothenburg, Sweden; S. Del Prato, Pisa, Italy; C. Bailey, Birmingham, UK; and B. Charbonnel, Nantes, France). Simultaneous publication: This article is being simultaneously published in 2006 in Diabetes Care and Diabetologia by the American Diabetes Association and the European Association for the Study of Diabetes. Copyright 2006 by the American Diabetes Association, Inc. and Springer. Copying with attribution allowed for any noncommercial use of the work.
引用
收藏
页码:1711 / 1721
页数:11
相关论文
共 76 条
  • [1] VETERANS AFFAIRS COOPERATIVE STUDY ON GLYCEMIC CONTROL AND COMPLICATIONS IN TYPE-II DIABETES (VA CSDM) - RESULTS OF THE FEASIBILITY TRIAL
    ABRAIRA, C
    COLWELL, JA
    NUTTALL, FQ
    SAWIN, CT
    NAGEL, NJ
    COMSTOCK, JP
    EMANUELE, NV
    LEVIN, SR
    HENDERSON, W
    LEE, HS
    [J]. DIABETES CARE, 1995, 18 (08) : 1113 - 1123
  • [2] *AM DIAB ASS, 2005, DIABETES CARE S1, V28, pS15
  • [3] Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4
  • [4] [Anonymous], 1999, Diabet Med, V16, P716
  • [5] [Anonymous], 1995, DIABETES, V44, P968
  • [6] Rosiglitazone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: A 24-week, multicenter, randomized, double-blind, parallel-group study
    Bailey, CJ
    Bagdonas, A
    Rubes, J
    McMorn, SO
    Donaldson, J
    Biswas, N
    Stewart, MW
    [J]. CLINICAL THERAPEUTICS, 2005, 27 (10) : 1548 - 1561
  • [7] Drug therapy - Metformin
    Bailey, CJ
    Turner, RC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) : 574 - 579
  • [8] BASTIEN A, 2004, PRACT DIABETOL, V23, P6
  • [9] Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes
    Buse, JB
    Henry, RR
    Han, J
    Kim, DD
    Fineman, MS
    Baron, AD
    [J]. DIABETES CARE, 2004, 27 (11) : 2628 - 2635
  • [10] Inhaled human insulin treatment in patients with type 2 diabetes mellitus
    Cefalu, WT
    Skyler, JS
    Kourides, IA
    Landschulz, WH
    Balagtas, CC
    Cheng, SL
    Gelfand, RA
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 134 (03) : 203 - 207